|
1
|
Inui A: Cancer anorexia-cachexia syndrome:
Current issues in research and management. CA Cancer J Clin.
52:72–91. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Costelli P and Baccino FM: Cancer
cachexia: From experimental models to patient management. Curr Opin
Clin Nutr Metab Care. 3:177–181. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fearon KC, Glass DJ and Guttridge DC:
Cancer cachexia: Mediators, signaling, and metabolic pathways. Cell
Metab. 16:153–166. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Onesti JK and Guttridge DC: Inflammation
based regulation of cancer cachexia. Biomed Res Int.
2014:1684072014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ando K, Takahashi F, Motojima S, Nakashima
K, Kaneko N, Hoshi K and Takahashi K: Possible role for
tocilizumab, an anti-interleukin-6 receptor antibody, in treating
cancer cachexia. J Clin Oncol. 31:e69–e72. 2013. View Article : Google Scholar
|
|
6
|
Gallagher IJ, Stephens NA, MacDonald AJ,
Skipworth RJ, Husi H, Greig CA, Ross JA, Timmons JA and Fearon KC:
Suppression of skeletal muscle turnover in cancer cachexia:
Evidence from the transcriptome in sequential human muscle
biopsies. Clin Cancer Res. 18:2817–2827. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bruera E: ABC of palliative care.
Anorexia, cachexia, and nutrition. BMJ. 315:1219–1222. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nicolini A, Ferrari P, Masoni MC, Fini M,
Pagani S, Giampietro O and Carpi A: Malnutrition, anorexia and
cachexia in cancer patients: A mini-review on pathogenesis and
treatment. Biomed Pharmacother. 67:807–817. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Argilés JM, Costelli P, Carbó N,
Pallarés-Trujillo J and López-Soriano FJ: Tumour growth and
nitrogen metabolism in the host (Review). Int J Oncol. 14:479–486.
1999.PubMed/NCBI
|
|
10
|
Jagoe RT and Goldberg AL: What do we
really know about the ubiquitin-proteasome pathway in muscle
atrophy? Curr Opin Clin Nutr Metab Care. 4:183–190. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bonetto A, Aydogdu T, Jin X, Zhang Z, Zhan
R, Puzis L, Koniaris LG and Zimmers TA: JAK/STAT3 pathway
inhibition blocks skeletal muscle wasting downstream of IL-6 and in
experimental cancer cachexia. Am J Physiol Endocrinol Metab.
303:E410–E421. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Narsale AA and Carson JA: Role of
interleukin-6 in cachexia: Therapeutic implications. Curr Opin
Support Palliat Care. 8:321–327. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bodine SC and Baehr LM: Skeletal muscle
atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1. Am
J Physiol Endocrinol Metab. 307:E469–E484. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ogawa T, Furochi H, Mameoka M, et al:
Ubiquitin ligase gene expression in healthy volunteers with 20-day
bedrest. Muscle Nerve. 34:463–469. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Urso ML, Chen YW, Scrimgeour AG, Lee PC,
Lee KF and Clarkson PM: Alterations in mRNA expression and protein
products following spinal cord injury in humans. J Physiol.
579:877–892. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Léger B, Vergani L, Sorarù G, Hespel P,
Derave W, Gobelet C, D’Ascenzio C, Angelini C and Russell AP: Human
skeletal muscle atrophy in amyotrophic lateral sclerosis reveals a
reduction in Akt and an increase in atrogin-1. FASEB J. 20:583–585.
2006.PubMed/NCBI
|
|
17
|
Doucet M, Dubé A, Joanisse DR, Debigaré R,
Michaud A, Paré MÈ, Vaillancourt R, Fréchette E and Maltais F:
Atrophy and hypertrophy signalling of the quadriceps and diaphragm
in COPD. Thorax. 65:963–970. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Clavel S, Coldefy AS, Kurkdjian E, Salles
J, Margaritis I and Derijard B: Atrophy-related ubiquitin ligases,
atrogin-1 and MuRF1 are up-regulated in aged rat Tibialis Anterior
muscle. Mech Ageing Dev. 127:794–801. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dehoux M, Van Beneden R, Pasko N, Lause P,
Verniers J, Underwood L, Ketelslegers JM and Thissen JP: Role of
the insulin-like growth factor I decline in the induction of
atrogin-1/MAFbx during fasting and diabetes. Endocrinology.
145:4806–4812. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lecker SH, Jagoe RT, Gilbert A, Gomes M,
Baracos V, Bailey J, Price SR, Mitch WE and Goldberg AL: Multiple
types of skeletal muscle atrophy involve a common program of
changes in gene expression. FASEB J. 18:39–51. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bossola M, Muscaritoli M, Costelli P,
Grieco G, Bonelli G, Pacelli F, Rossi Fanelli F, Doglietto GB and
Baccino FM: Increased muscle proteasome activity correlates with
disease severity in gastric cancer patients. Ann Surg. 237:384–389.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li YP, Schwartz RJ, Waddell ID, Holloway
BR and Reid MB: Skeletal muscle myocytes undergo protein loss and
reactive oxygen-mediated NF-kappaB activation in response to tumor
necrosis factor alpha. FASEB J. 12:871–880. 1998.PubMed/NCBI
|
|
23
|
Zhou CF, Li XB, Sun H, Zhang B, Han YS,
Jiang Y, Zhuang QL, Fang J and Wu GH: Pyruvate kinase type M2 is
upregulated in colorectal cancer and promotes proliferation and
migration of colon cancer cells. IUBMB Life. 64:775–782. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Khal J, Hine AV, Fearon KC, Dejong CH and
Tisdale MJ: Increased expression of proteasome subunits in skeletal
muscle of cancer patients with weight loss. Int J Biochem Cell
Biol. 37:2196–2206. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
D’Orlando C, Marzetti E, François S, et
al: Gastric cancer does not affect the expression of
atrophy-related genes in human skeletal muscle. Muscle Nerve.
49:528–533. 2014. View Article : Google Scholar
|
|
26
|
Yasumoto K, Mukaida N, Harada A, et al:
Molecular analysis of the cytokine network involved in cachexia in
colon 26 adenocarcinoma-bearing mice. Cancer Res. 55:921–927.
1995.PubMed/NCBI
|
|
27
|
Iizuka N, Hazama S, Yoshimura K, Yoshino
S, Tangoku A, Miyamoto K, Okita K and Oka M: Anticachectic effects
of the natural herb Coptidis rhizoma and berberine on mice bearing
colon 26/clone 20 adenocarcinoma. Int J Cancer. 99:286–291. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pajak B, Orzechowska S, Pijet B, Pijet M,
Pogorzelska A, Gajkowska B and Orzechowski A: Crossroads of
cytokine signaling - the chase to stop muscle cachexia. J Physiol
Pharmacol. 59(Suppl 9): S251–S264. 2008.
|
|
29
|
Li YP, Chen Y, John J, Moylan J, Jin B,
Mann DL and Reid MB: TNF-alpha acts via p38 MAPK to stimulate
expression of the ubiquitin ligase atrogin1/MAFbx in skeletal
muscle. FASEB J. 19:362–370. 2005. View Article : Google Scholar : PubMed/NCBI
|
